{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:07:53Z","timestamp":1746331673781,"version":"3.40.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune encephalitis characterized by diverse neurological and psychiatric symptoms. It predominantly affects young women, particularly those with ovarian teratomas. However, cases without teratomas are also commonly reported, often exhibiting poorer treatment responses and higher relapse rates. Persistent fever and signs of meningitis are rare in such cases. Diagnosis is confirmed through the detection of anti-NMDAR antibodies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 15-year-old female presented with episodic loss of consciousness, fever, nuchal rigidity, limb convulsions, and psychiatric symptoms following a stressful exam period. Initial symptomatic treatments were ineffective.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The diagnosis of anti-NMDAR encephalitis was confirmed through lumbar puncture, brain imaging, and the detection of anti-NMDAR antibodies in cerebrospinal fluid and serum.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient received tailored first-line therapy, including high-dose methylprednisolone and 3 courses of intravenous immunoglobulin (IVIG).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient exhibited significant clinical improvement, with a reduction in seizure frequency and eventual complete seizure control. Body temperature normalized, and follow-up showed progressive recovery in cognitive and motor functions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case highlights the importance of early diagnosis and individualized treatment in anti-NMDAR encephalitis. Repeated IVIG courses proved effective, underscoring the need for personalized treatment plans in managing this condition. Persistent fever and signs of meningitis were rare and contributed to the diagnostic challenge, highlighting the clinical complexity of this case.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040803","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T21:03:32Z","timestamp":1733778212000},"page":"e40803","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anti-NMDAR encephalitis presenting with persistent fever and meningitis and responding well to distinctive individualized first-line treatment: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5922-6482","authenticated-orcid":false,"given":"Xin","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Neurology, Second Affiliated Hospital of Naval Medical University, Shanghai Changzheng Hospital, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Affiliated Hospital of Naval Medical University, Shanghai Changzheng Hospital, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Affiliated Hospital of Naval Medical University, Shanghai Changzheng Hospital, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic Anti-N-Methyl-D-Aspartate receptor encephalitis associated with ovarian teratoma.","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"7506590","DOI":"10.1155\/2020\/7506590","article-title":"Current progress on assessing the prognosis for anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis.","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res Int"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/bs.apha.2017.08.005","article-title":"Anti-NMDA receptor encephalitis: clinical features and basic mechanisms.","volume":"82","author":"Lynch","year":"2018","journal-title":"Adv Pharmacol"},{"issue":"Suppl 1","key":"R5-20250504","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.33549\/physiolres.932678","article-title":"Structure, function, and pharmacology of NMDA receptor channels.","volume":"63","author":"Vyklicky","year":"2014","journal-title":"Physiol Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fneur.2019.00178","article-title":"An assay to determine mechanisms of rapid autoantibody-induced neurotransmitter receptor endocytosis and vesicular trafficking in autoimmune encephalitis.","volume":"10","author":"Amedonu","year":"2019","journal-title":"Front Neurol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/1871527319666200708133103","article-title":"Autoimmune encephalitis: current knowledge on subtypes, disease mechanisms and treatment.","volume":"19","author":"Nissen","year":"2020","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00404-020-05645-9","article-title":"Anti-NMDA receptor encephalitis associated with ovarian tumor: the gynecologist point of view.","volume":"302","author":"Delangle","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis.","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.braindev.2016.01.009","article-title":"Plasma exchange in pediatric anti-NMDAR encephalitis: a systematic review.","volume":"38","author":"Suppiej","year":"2016","journal-title":"Brain Dev"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12879-020-4761-1","article-title":"Case report: meningitis as a presenting feature of anti-NMDA receptor encephalitis.","volume":"20","author":"Stavrou","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","article-title":"Use and safety of immunotherapeutic management of N-methyl-D-aspartate receptor antibody encephalitis: a meta-analysis.","volume":"78","author":"Nosadini","year":"2021","journal-title":"JAMA Neurol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003693305700200504","article-title":"Cerebral vascular accidents in patients over the age of 60. II. Prognosis.","volume":"2","author":"Rankin","year":"1957","journal-title":"Scott Med J"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness. a practical scale.","volume":"2","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/apnr.2000.9231","article-title":"An examination of psychometric properties of the mini-mental state examination and the standardized mini-mental state examination: implications for clinical practice.","volume":"13","author":"Pangman","year":"2000","journal-title":"Appl Nurs Res"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment.","volume":"53","author":"Asreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"Pt 6","key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-Methyl-D-Aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"R22-20250504","first-page":"4299791","article-title":"Anti-NMDA receptor encephalitis: retrospective analysis of 15 cases, literature review, and implications for gynecologists.","volume":"2022","author":"Liu","year":"2022","journal-title":"J Healthc Eng"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e01012","DOI":"10.1002\/brb3.1012","article-title":"Prodromal headache in Anti-NMDAR encephalitis: an epiphenomenon of NMDAR autoimmunity.","volume":"8","author":"Tominaga","year":"2018","journal-title":"Brain Behav"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1212\/NXI.0000000000000633","article-title":"Anti-NMDAR encephalitis: a single-center, longitudinal study in China.","volume":"7","author":"Xu","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10072-020-04785-9","article-title":"HSV encephalitis triggered anti-NMDAR encephalitis: a case report.","volume":"42","author":"Hu","year":"2021","journal-title":"Neurol Sci"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases.","volume":"367","author":"Gelfand","year":"2012","journal-title":"N Engl J Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.4049\/jimmunol.1201965","article-title":"Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis.","volume":"190","author":"Othy","year":"2013","journal-title":"J Immunol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10875-011-9546-2","article-title":"Incidence of infection is inversely related to steady-state. (Trough) serum IgG level in studies of subcutaneous IgG in PIDD.","volume":"31","author":"Berger","year":"2011","journal-title":"J Clin Immunol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence.","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies.","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00918268","article-title":"Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): kinetics of immunoglobulin metabolism.","volume":"12","author":"Chapel","year":"1992","journal-title":"J Clin Immunol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/1744666X.2017.1232165","article-title":"Kawasaki disease: etiopathogenesis and novel treatment strategies.","volume":"13","author":"Agarwal","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1196\/annals.1405.038","article-title":"Ivig treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.","volume":"1132","author":"Zinman","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/BOR.0000000000000599","article-title":"Treatment of primary and secondary immune thrombocytopenia.","volume":"31","author":"Kado","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bpobgyn.2019.07.005","article-title":"Immunotherapy for recurrent pregnancy loss.","volume":"60","author":"Carp","year":"2019","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11940-019-0550-9","article-title":"Diagnosis and management of autoimmune dementia.","volume":"21","author":"Sechi","year":"2019","journal-title":"Curr Treat Options Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:09:37Z","timestamp":1746320977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":37,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040803","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}